Viral Epidemiology and Immunity Unit, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Institute of Child Health and Human Development, National Institutes of Health, University of the Philippines-Manila, Manila, Philippines.
BMC Infect Dis. 2024 Sep 27;24(1):1042. doi: 10.1186/s12879-024-09672-8.
SARS-CoV-2, the causative agent of COVID-19, is a betacoronavirus belonging to the same genus as endemic human coronaviruses (hCoVs) OC43 and HKU1 and is distinct from alpha hCoVs 229E and NL63. In a study of adolescents in the Philippines, we evaluated seroprevalence to the hCoVs, whether pre-pandemic hCoV immunity modulated subsequent risk of SARS-CoV-2 infection, and if SARS-CoV-2 infection affected the transmission of the hCoVs.
From 499 individuals screened in 2021 for SARS-CoV-2 receptor binding domain (RBD) antibodies by enzyme-linked immunosorbent assay (ELISA), we randomly selected 59 SARS-CoV-2 negative and 61 positive individuals for further serological evaluation. We measured RBD and spike antibodies to the four hCoVs and SARS-CoV-2 by ELISA in samples from the same participants collected pre-pandemic (2018-2019) and mid-pandemic (2021), before COVID-19 vaccination.
We observed over 72% seropositivity to the four hCoVs pre-pandemic. Binding antibodies increased with age to 229E and OC43, suggesting endemic circulation, while antibody levels was flat across ages for HKU1 and NL63. During the COVID-19 pandemic, antibodies increased significantly to the RBDs of OC43, NL63, and 229E and spikes of all four hCoVs in both SARS-CoV-2 negative and positive adolescents. Those aged 12-15 years old in 2021 had higher antibodies to RBD and spike of OC43, NL63, and 229E than adolescents the same age in 2019, further demonstrating intense transmission of the hCoVs during the pandemic.
We observe a limited impact of the COVID-19 pandemic on endemic hCoV transmission. This study provides insight into co-circulation of hCoVs and SARS-CoV-2.
SARS-CoV-2 是 COVID-19 的病原体,属于贝塔冠状病毒,与地方性人类冠状病毒(hCoV)OC43 和 HKU1 同属一个属,与 alpha hCoV 229E 和 NL63 不同。在菲律宾对青少年进行的一项研究中,我们评估了针对 hCoV 的血清流行率,是否在大流行前的 hCoV 免疫会调节随后感染 SARS-CoV-2 的风险,以及 SARS-CoV-2 感染是否会影响 hCoV 的传播。
从 2021 年通过酶联免疫吸附试验(ELISA)筛查的 499 名个体中,我们随机选择了 59 名 SARS-CoV-2 阴性和 61 名阳性个体进行进一步的血清学评估。我们使用 ELISA 测量了同一参与者在大流行前(2018-2019 年)和大流行中期(2021 年)收集的样本中针对四种 hCoV 和 SARS-CoV-2 的 RBD 和刺突抗体。
我们观察到在大流行前,四种 hCoV 的血清阳性率超过 72%。结合抗体随年龄增长到 229E 和 OC43 增加,表明存在地方性循环,而对于 HKU1 和 NL63,抗体水平在整个年龄段保持不变。在 COVID-19 大流行期间,SARS-CoV-2 阴性和阳性青少年的 OC43、NL63 和 229E 的 RBD 和所有四种 hCoV 的刺突的抗体均显著增加。2021 年 12-15 岁的青少年的 OC43、NL63 和 229E 的 RBD 和刺突抗体高于 2019 年同年龄的青少年,进一步证明了大流行期间 hCoV 的强烈传播。
我们观察到 COVID-19 大流行对地方性 hCoV 传播的影响有限。本研究提供了有关 hCoV 和 SARS-CoV-2 共同循环的见解。